A new guideline from AAN offers recommendations on the use of behavioral, nutraceutical, and complementary and alternative medicine (CAM) for improving sleep disorders in children with ASD.
Researchers explored habitual sleep, social jetlag, and day-to-day variations in sleep among youth with DSWPD compared with healthy controls.
In boys but not girls, reduced sleep duration at age 8 and 10 years predicted the development of behavioral disorder symptoms 2 years later.
Previous studies have shown that sleep efficiency decreases with age, but additional factors may have an important role.
The FDA has approved lemborexant for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance in adult patients.
Postmenopausal women more often have sleep-onset insomnia disorder and are more likely to screen positive for obstructive sleep apnea.
In this sample of preschoolers, sleep disorders were commonly reported and associated with specific diagnostic categories.
The researchers found that adults with ASD showed significant impairments in both objective and subjective measures of sleep compared with controls.
Anna S. Urrila, MD and colleagues sought to explore whether sleep symptoms in adolescents with MDD were associated with long-term outcomes.
Sleep-wake disturbances affect approximately 50% of children with acquired brain injury, and many children with preadmission chronic conditions have an increased risk for sleep-wake disturbances, a study in Pediatric Neurology suggests. A total of 78 children (median age, 9.9 years) with acquired brain injury who had been released from critical care hospitalization within 3 months…
